• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急慢性肝病中的代谢紊乱

Metabolic Derangement in Acute and Chronic Liver Disorders.

作者信息

Bajaj Sarita, Kashyap Richi, Srivastava Anubha, Singh Smriti

机构信息

Department of Medicine, Motilal Nehru Medical College, Allahabad, Uttar Pradesh, India.

出版信息

Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):695-698. doi: 10.4103/ijem.IJEM_146_17.

DOI:10.4103/ijem.IJEM_146_17
PMID:28989876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5628538/
Abstract

AIMS

This study aims to assess glycemic and lipid derangement in acute and chronic liver disorders.

MATERIALS AND METHODS

A cross-sectional study was conducted on 104 patients diagnosed with acute or chronic liver disorder. Acute liver disease (ALD) patients were 40 and chronic liver disease (CLD) patients were 64.

RESULTS

The mean value of fasting plasma glucose (FPG) in patients with ALD was 91.8 ± 5.4 mg/dl and in CLD was 115.7 ± 17.9 mg/dl, the difference was significant. The mean value of A1c was 4.3 ± 0.6 in ALD and 6.1 ± 0.8 in CLD, the difference was significant. In patients with CLD mean cholesterol was higher 177.4 ± 28.8 mg/dl when compared to ALD 140 ± 35.1 mg/dl, but the difference was not significant. ALD patients' high-density lipoprotein (HDL) was 50.4 ± 5.1 mg/dl, and in CLD patients, HDL was 44.4 ± 6.1 mg/dl. In CLD mean triglyceride (T) was 148.9 ± 6.4 mg/dl while in ALD T was 134.8 ± 14.2 mg/dl, the difference was significant.

CONCLUSIONS

CLD is associated with glycemic derangement demonstrated by deranged FPG and A1c. In patients of ALD, no metabolic derangement was observed.

摘要

目的

本研究旨在评估急慢性肝脏疾病中的血糖和血脂紊乱情况。

材料与方法

对104例诊断为急慢性肝脏疾病的患者进行了一项横断面研究。急性肝病(ALD)患者40例,慢性肝病(CLD)患者64例。

结果

ALD患者空腹血糖(FPG)平均值为91.8±5.4mg/dl,CLD患者为115.7±17.9mg/dl,差异有统计学意义。ALD患者糖化血红蛋白(A1c)平均值为4.3±0.6,CLD患者为6.1±0.8,差异有统计学意义。CLD患者平均胆固醇水平高于ALD患者,分别为177.4±28.8mg/dl和140±35.1mg/dl,但差异无统计学意义。ALD患者高密度脂蛋白(HDL)为50.4±5.1mg/dl,CLD患者为44.4±6.1mg/dl。CLD患者平均甘油三酯(T)为148.9±6.4mg/dl,ALD患者为134.8±14.2mg/dl,差异有统计学意义。

结论

CLD与FPG和A1c紊乱所显示的血糖紊乱有关。在ALD患者中,未观察到代谢紊乱。

相似文献

1
Metabolic Derangement in Acute and Chronic Liver Disorders.急慢性肝病中的代谢紊乱
Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):695-698. doi: 10.4103/ijem.IJEM_146_17.
2
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).非酒精性脂肪性肝病与美国 30 天内再次住院的风险增加相关。
Ann Hepatol. 2023 Jul-Aug;28(4):101108. doi: 10.1016/j.aohep.2023.101108. Epub 2023 Apr 23.
3
Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD).高密度脂蛋白胆固醇(HDL-C)作为慢性肝病(CLD)患者失代偿临床预测指标的作用。
Int J Hepatol. 2021 Dec 24;2021:1795851. doi: 10.1155/2021/1795851. eCollection 2021.
4
Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital.慢性肝病患者空腹血脂谱的相关性:一项在三级医疗医院进行的描述性横断面研究。
Cureus. 2020 Oct 18;12(10):e11019. doi: 10.7759/cureus.11019.
5
Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.慢性肝病患者的基础及蛋氨酸负荷后血清同型半胱氨酸和脂蛋白异常
J Investig Med. 2001 Jul;49(4):325-9. doi: 10.2310/6650.2001.33897.
6
Assessment of adrenal function in liver diseases.肝脏疾病中肾上腺功能的评估。
Indian J Endocrinol Metab. 2013 May;17(3):465-71. doi: 10.4103/2230-8210.111643.
7
Serum uric acid level in chronic liver disease and its correlation with Child-Pugh score in a tertiary care hospital from South India.印度南部一家三级医疗医院慢性肝病患者的血清尿酸水平及其与Child-Pugh评分的相关性
J Family Med Prim Care. 2023 Nov;12(11):2696-2701. doi: 10.4103/jfmpc.jfmpc_847_23. Epub 2023 Nov 21.
8
Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- thunb. induced liver injury: a case-control study from a specialised liver disease center in China.在一项来自中国专门肝病中心的病例对照研究中,与预先存在的慢性肝病并存与草药性肝损伤患者的预后较差相关。
BMJ Open. 2019 Jan 15;9(1):e023567. doi: 10.1136/bmjopen-2018-023567.
9
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.糖尿病分类与诊断标准委员会报告。
Diabetes Res Clin Pract. 2002 Jan;55(1):65-85. doi: 10.1016/s0168-8227(01)00365-5.
10
Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease.印度慢性肝病患者的病因模式、肝纤维化阶段及肝保护剂的处方模式
J Assoc Physicians India. 2018 Dec;66(12):58-63.

引用本文的文献

1
Upregulation of CCL5/RANTES Gene Expression in the Diaphragm of Mice with Cholestatic Liver Disease.胆汁淤积性肝病小鼠膈肌中 CCL5/RANTES 基因表达上调。
Adv Exp Med Biol. 2023;1408:201-218. doi: 10.1007/978-3-031-26163-3_11.

本文引用的文献

1
Standards of medical care in diabetes--2014.2014年糖尿病医疗护理标准
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014.
2
Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population.糖化血红蛋白与老年中国人非酒精性脂肪性肝病的独立相关性。
BMC Gastroenterol. 2013 Jan 7;13:3. doi: 10.1186/1471-230X-13-3.
3
Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia.乙型肝炎病毒感染和丙氨酸氨基转移酶水平升高对血脂异常的联合影响。
Metabolism. 2013 Feb;62(2):220-5. doi: 10.1016/j.metabol.2012.07.022. Epub 2012 Aug 28.
4
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
5
Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects.非酒精性脂肪性肝病对非糖尿病患者 HbA1c 水平相关胰岛素抵抗的影响。
Am J Gastroenterol. 2010 Nov;105(11):2389-95. doi: 10.1038/ajg.2010.275. Epub 2010 Jul 13.
6
Impact of diabetes on the severity of liver disease.糖尿病对肝脏疾病严重程度的影响。
Am J Med. 2007 Oct;120(10):829-34. doi: 10.1016/j.amjmed.2007.03.025.
7
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication.在乙肝和丙肝流行地区,丙型肝炎病毒血症增加了与2型糖尿病的关联:一种具有病毒学意义的流行病学联系。
Am J Gastroenterol. 2007 Jun;102(6):1237-43. doi: 10.1111/j.1572-0241.2007.01181.x.
8
High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.丙型肝炎病毒感染患者中血糖异常的高患病率:一项考虑肝损伤的多变量分析。
Diabetes Care. 2004 May;27(5):1171-5. doi: 10.2337/diacare.27.5.1171.
9
Effects of ethanol on lipids and atherosclerosis.乙醇对脂质及动脉粥样硬化的影响。
Pathophysiology. 2004 Apr;10(2):93-103. doi: 10.1016/j.pathophys.2003.10.009.
10
Clinical implications of hepatogenous diabetes in liver cirrhosis.肝硬化中肝源性糖尿病的临床意义。
J Gastroenterol Hepatol. 2002 Jun;17(6):677-81. doi: 10.1046/j.1440-1746.2002.02755.x.